Healthcare
Thursday, April 14, 2016
BRIEF-Neovacs gets approval of South Korean healthcare regulator for Phase IIb trial with Lupus
* Gets approval of South Korean healthcare regulator for
Phase IIb trial with Lupus
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment